معرفی
Shan-Lu Liu is a Professor and Director of the Viruses and Emerging Pathogens Program at the Infectious Disease Institute, The Ohio State University. His research focuses on molecular virology, virus-host interactions, innate immunity, and cell signaling. He holds an M.D. from Zhengzhou University School of Medicine (1989) and a Ph.D. in Microbiology from the University of Washington School of Medicine (2003), followed by postdoctoral training at the University of Washington and Fred Hutchinson Cancer Research Center.
Research interests include host restriction mechanisms against viral infections, viral cell-to-cell transmission, and immune responses to SARS-CoV-2. Key projects involve IFITM proteins' role in viral entry inhibition, Ebola virus fusion mechanisms, and HIV Nef's interaction with TIM proteins. He investigates SARS-CoV-2 variants' immune evasion and cell-cell fusion dynamics, with recent work on Omicron subvariants and vaccine development.
Dr. Liu's affiliations include the Center for Retrovirus Research, Biomedical Sciences Graduate Program, and Molecular, Cellular, and Developmental Biology Program. His work spans viral pathogenesis, host defense mechanisms, and translational strategies to combat emerging pathogens.
